Table 3.
Cumulative live birth of different ovarian stimulation protocols in different age brackets.-, not analyzed since the number of the subjects is <15.
| Total | 38/39y | 40/41y | 42/43y | ≥44y | |
|---|---|---|---|---|---|
| N=424 | N=226 | N=118 | N=58 | ||
| GnRH antagonist | 22.0% | 27.4% | 29.6% | 10.7% | 2.7% |
| (68/309) | (37/135) | (24/81) | (6/56) | (1/37) | |
| GnRH-a long | 33.2% | 38.7% | 23.4% | 23.1% | – |
| (73/220) | (55/142) | (11/47) | (6/26) | (1/5) | |
| Micro-stimulation | 20.5% | 22.1% | 24.1% | 17.9% | – |
| (36/176) | (17/77) | (14/58) | (5/28) | (0/13) | |
| GnRH-a ultra-long | 38.2% | 42.2% | 37.5% | – | – |
| (39/102) | (27/64) | (12/32) | (0/5) | (0/1) | |
| Progestin primed ovarian stimulation | 10.5% | – | – | – | – |
| (2/19) | (1/6) | (1/8) | (0/3) | (0/2) | |
| P | <0.001 | 0.014 | 0.482 | 0.307 | – |